Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01106404 · ClinicalTrials.gov registry record · NA

RestoreSensor Study

A NA study of Chronic Pain, sponsored by MedtronicNeuro.

Completed
Registry status
NA
Development phase
79
Enrollment target
10
Study locations

NCT01106404 is a NA study of Chronic Pain that has completed, run by MedtronicNeuro. The registered enrollment target is 79 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01106404, a NA study of Chronic Pain, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target
10
Study locations

Study Summary

The purpose of the study is to gather clinical information on subjects' experiences with and without the use of the new feature of the RestoreSensor implantable neurostimulator (INS).

Conditions Studied

Interventions

  • DEVICE RestoreSensor Neurostimulation System

Study Locations (10)

Texas

  • - Dallas
  • - San Antonio
  • - San Antonio

Alabama

  • - Huntsville

California

  • - Oceanside

Minnesota

  • - Edina

Nevada

  • - Las Vegas

New Jersey

  • - Voorhees Township

Oregon

  • - Eugene

Utah

  • - Salt Lake City

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2010-04
Est. Completion 2011-01
Phase NA

Sponsor

MedtronicNeuro

51 total trials

What the Registry Record Tells You About NCT01106404

The ClinicalTrials.gov registry entry for NCT01106404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which RestoreSensor Neurostimulation System is the first listed.

NCT01106404 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Texas, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT01106404 about?

NCT01106404 is a clinical study titled "RestoreSensor Study". The purpose of the study is to gather clinical information on subjects' experiences with and without the use of the new feature of the RestoreSensor implantable neurostimulator (INS).

What is the current status of trial NCT01106404?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2010-04. Estimated completion is 2011-01.

What conditions does trial NCT01106404 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT01106404?

The interventions under investigation include: RestoreSensor Neurostimulation System (DEVICE).

Who is sponsoring clinical trial NCT01106404?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01106404 being conducted?

This trial has 10 study locations across Alabama, California, Minnesota, Nevada, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.